Table 3.
AIDS study.
JM | JM | ||||||||
---|---|---|---|---|---|---|---|---|---|
Parameter | Name of the effect | Mean | SD | 95% CI | Mean | SD | 95% CI | ||
For longitudinal | |||||||||
Intercept | 2.599 | 0.102 | 2.403 | 2.798 | 2.604 | 0.094 | 2.425 | 2.793 | |
Obs. time | −0.398 | 0.039 | −0.475 | −0.322 | −0.401 | 0.039 | −0.479 | −0.323 | |
Drug | 0.088 | 0.095 | −0.094 | 0.278 | 0.075 | 0.095 | −0.106 | 0.259 | |
Gender | −0.003 | 0.081 | −0.159 | 0.156 | −0.010 | 0.082 | −0.173 | 0.148 | |
Prev opp infection | −0.442 | 0.059 | −0.553 | −0.326 | −0.433 | 0.059 | −0.548 | −0.324 | |
Intol to ZDV | −0.028 | 0.059 | −0.143 | 0.089 | −0.042 | 0.057 | −0.156 | 0.065 | |
Precision | 3.239 | 0.134 | 2.985 | 3.506 | 3.232 | 0.134 | 2.976 | 3.902 | |
For both processes | |||||||||
covariance between two processes | 0.501 | 0.289 | 0.024 | 0.974 | 0.497 | 0.289 | 0.023 | 0.975 | |
variance component | 0.203 | 0.046 | 0.123 | 0.294 | 0.211 | 0.046 | 0.126 | 0.308 | |
correlation | −0.216 | 0.099 | −0.395 | −0.005 | −0.209 | 0.097 | −0.392 | −0.021 | |
For time-to-event | |||||||||
Intercept | 0.904 | 1.118 | −1.277 | 3.069 | 0.904 | 1.110 | −1.272 | 3.064 | |
precision | 1.002 | 0.101 | 0.812 | 1.208 | 0.999 | 0.099 | 0.813 | 1.204 | |
random intercept | 1.000 | 0.100 | 0.806 | 1.195 | |||||
random slope | 1.000 | 0.099 | 0.805 | 1.193 |
Note: Results of model fitting. Bold implies significant covariates